Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled...

Area of Science:

• Neurology
• Pharmacology
• Women's Health

Background:

• Menstrual migraine, often accompanied by dysmenorrhea, significantly impacts women's quality of life.
• Early intervention during the mild pain phase is crucial for effective migraine management.

Purpose of the Study:

• To assess the efficacy and tolerability of a fixed-dose combination of sumatriptan and naproxen (sumatriptan-naproxen) for menstrual migraine with dysmenorrhea.
• To evaluate the treatment's effectiveness when administered during the mild pain phase of an attack.

Main Methods:

• Two randomized, double-blind, placebo-controlled trials involving adults with menstrual migraine and dysmenorrhea.
• Participants received either sumatriptan-naproxen or placebo at the onset of mild pain, treating a single migraine attack.
• The primary outcome measured was the proportion of participants who were pain-free at 2 hours post-treatment.

Main Results:

• Sumatriptan-naproxen demonstrated statistically significant superiority over placebo in achieving a 2-hour pain-free response in both studies.
• Sustained pain relief was observed from 2 to 24 hours and up to 48 hours with sumatriptan-naproxen compared to placebo.
• The treatment group showed reduced use of rescue medications for both headache and menstrual symptoms, alongside relief of non-painful menstrual symptoms.

Conclusions:

• Sumatriptan-naproxen is an effective treatment for menstrual migraine associated with dysmenorrhea, providing rapid and sustained pain relief.
• The combination therapy is well-tolerated and offers additional benefits by reducing the need for rescue medications and alleviating other menstrual symptoms.